Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Haruo Sugano is active.

Publication


Featured researches published by Haruo Sugano.


Cancer | 1988

Mucinous carcinoma of the breast in Japan. A prognostic analysis based on morphologic features

Kansei Komaki; Goi Sakamoto; Haruo Sugano; Tadaoki Morimoto; Yasumasa Monden

In 175 women with mucinous carcinoma (MC) of the breast, the morphologic features, the clinicopathological features (age, tumor size, and nodal status) and prognoses were investigated. They were divided into two types, those with “unmixed type” (n = 140) showing no component of invasive ductal carcinoma (IDC) and “mixed type” (n = 35) including an IDC component. The unmixed type showed less frequent (P < 0.01) nodal involvement and a higher degree (P < 0.005) of extracellular mucus production than the mixed type. The presence of nodal metastases showed no correlation with the degree of mucus production. The 10‐year survival rate of the unmixed type (90.4%) was better (P < 0.001) than in the mixed type (66.0%). In the unmixed type, a higher level of mucus production showed trends toward a better prognosis, younger age and smaller tumor size (P < 0.01). In the mixed type, the degree of mucus production showed no significant correlation with either the age, tumor size, or prognosis. It is more important for the prognosis of patients with MC to have no IDC component than to show abundant mucus within the tumor.


Cancer | 1977

Circumscribed carcinoma of the uterine cervix, with marked lymphocytic infiltration.

Katsuhiko Hasumi; Haruo Sugano; Goi Sakamoto; Kazumasa Masubuchi; Hisamitsu Kubo

The present study was carried out to investigate a distinctive type of carcinoma of the uterine cervix categorized under the designation as circumscribed carcinoma with lymphocytic infiltration. Grossly this carcinoma is characterized by defined circumscription with a superficial ulceration. A microscopic feature characteristic of this tumor is the presence of a loose fibrillary stroma infiltrated densely and uniformly by lymphocytes throughout the tumor mass. The tumor is arranged in solid cords separated by a lymphoid stroma with evidence of minimal squamous differentiation. The authors picked up 709 patients with carcinoma of the uterine cervix who underwent radical hysterectomy and pelvic lymphadenectomy at the Cancer Institute Hospital, Tokyo, between 1956–1967, without preoperative radio‐ or chemotherapy. Among them, 39 or 5.5% were identified as this type of carcinoma. Patients with this types of carcinoma had a significantly better prognosis than those with other types of cervical carcinoma of the same stage (p < 0.05). This favorable prognosis is probably due to the less regional node metastases found in the group. A proposal was made to segregate this particular type of carcinoma from other types of cervical carcinoma on the basis of its morphologic and prognostic distinctiveness.


Archive | 1981

Comparative Pathological Study of Breast Carcinoma among American and Japanese Women

Goi Sakamoto; Haruo Sugano; William H. Hartmann

Breast carcinoma among Japanese females is characterized by a relatively low incidence and good prognosis.(6) The recent annual death rate due to breast carcinoma among Japanese females is 5 per 100,000. This death rate is about one sixth of that among American females. According to Cancer Incidence in Five Continents,(2) the annual incidence of breast cancer per 100,000 Japanese females ranged from 12.1 in Osaka Prefecture to 16.6 in Okayama Prefecture. This incidence is very low when compared with that of American females. In Connecticut, the incidence is 71.7 per 100,000 females.


Preventive Medicine | 1978

Bilateral breast cancer and familial aggregations.

Goi Sakamoto; Haruo Sugano; Fujio Kasumi

Abstract Bilateral breast cancer and familial aggregation among Japanese female patients with breast cancer were studied and results were compared with those among American female patients. Out of 3365 female patients with breast cancer mastectomized at the Cancer Institute Hospital, Tokyo from 1946 to 1975, 92 cases were primary bilateral breast cancer. The crude incidence of bilateral cancer was 2.7%, whereas it was reported to range between 3.0% and 6.8% among American female patients. The true incidence rate of breast cancer after operation for unilateral breast cancer was calculated to be 3.4 per 1000 Japanese patients per year, while it was reported to be between 5.8 and 7.1 among American patients. These figures for American patients are roughly twice as large as those for Japanese females. In the bilateral breast cancer group, there was a high frequency of familial history of breast cancer, about three times higher than that in the unilateral breast cancer group. Further, in the bilateral breast cancer group, about half of the patients were nulliparous and 60% of the patients had breast cancers associated with fibrocystic disease in the same breast tissues. These figures were about three times greater than for those in the unilateral breast cancer group.


Archive | 1993

Biopsy Interpretation in Diagnosis of Gastric Carcinoma

Yo Kato; Akio Yanagisawa; Haruo Sugano

The interpretation of biopsy specimens from clinically obvious carcinomas, whether they appear in early or advanced stages, does not usually present any great problem. However, it is sometimes extremely difficult to evaluate changes because of the limited amounts of tissue available when small specimens are taken from so-called “borderline lesions”, i.e., neoplasias that are difficult to define as benign or malignant even when complete (surgically removed), or when artifacts are present due to the sampling process. Here, we present the histological criteria (group classification) widely used for diagnosis of gastric carcinoma in Japan and discuss how to manage problematic cases as well as several changes easily mistaken for carcinoma in routine examinations.


Experimental Biology and Medicine | 1968

Heme synthesis in Friend ascites tumor cells.

Shigeru Sassa; Fumimaro Takaku; Kikao Nako; Yoji Ikawa; Haruo Sugano

Summary Significant heme synthesis was observed in 2 Friend ascites tumor cell lines, when radioiron incorporation was measured and compared to Ehrlich ascites tumor cells and SN-36 ascites lymphoma cells.


Bibliotheca haematologica | 1975

Differentiation of Friend Virus-induced Leukemia Cells

Haruo Sugano; Tokuichi Kawaguchi; Mitsuru Furusawa; Yoji Ikawa

A long-term cultured Friend leukemia cell is able to differentiate along the erythrocytic series following treatment with some substances and that can be demonstrated by a conjugated erythrocyte membrane-specific antibody technique. Differentiation is induced by inhibition of DNA synthesis and by dimethylsulfoxide (DMSO), erythropoietin (EP) and Vitamin B12 (B12), and other agents. The effective substances were divided into 2 groups by the mode of differentiation of Friend cells. A differentiated state continues for several days when cells are re-cultured in the medium without substances. The decreased tumorigenecity of differentiated cells is proved by back transplantation to mice.


Journal of the National Cancer Institute | 1977

United States-Japan Cooperative Cancer Research Program

Guy R. Newell; Haruo Sugano

The formalization of long-standing cooperative joint research efforts between Japanese and U.S. scientists has resulted in the development of specific areas of mutual program interest. The overall future objective of this program is to foster and encourage collaboration of mutual interest and benefit.


Bibliotheca haematologica | 1973

Erythrocyte Membrane-Specific Antigens in Friend Virus-Induced Leukemia Cells1

Yoji Ikawa; Mitsuru Furusawa; Haruo Sugano


Bibliotheca haematologica | 1973

Enhancement of Erythrocytic Maturation of Friend Virus-Induced Leukemia Cells in vitro1

Haruo Sugano; Mitsuru Furusawa; Tokuichi Kawaguchi; Yoji Ikawa

Collaboration


Dive into the Haruo Sugano's collaboration.

Top Co-Authors

Avatar

Yoji Ikawa

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Goi Sakamoto

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Prince Masahito

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yo Kato

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Akio Yanagisawa

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge